Jam

Dassault Systèmes CEO Pascal Daloz now also chairs the board, consolidating leadership. Daloz, leading since 2020, has steered the software firm beyond traditional engineering into life sciences and urban planning. This dual role aims to quicken the rollout of the 3DEXPERIENCE platform, enhancing virtual twin capabilities for innovation. Analysts see this as a move towards unified leadership amid tech shifts, with a focus on AI and simulation for sustainable, intelligent solutions.

TREMFYRA® (guselkumab) has shown sustained clinical and endoscopic remission in ulcerative colitis patients over three years. This long-term data highlights the drug’s durability, a key factor in the competitive UC market. As a selective IL-23p19 inhibitor, TREMFYRA® targets inflammation precisely, potentially offering a favorable safety profile for chronic management. These findings strengthen its position as a valuable therapeutic option for moderate to severe UC.

Abivax presented significant findings on obefazimod at ECCO 2026, revealing its anti-fibrotic activity. Preclinical data demonstrated obefazimod’s potential to combat fibrosis, a key factor in IBD complications. This complements existing clinical data showing efficacy and a favorable safety profile in IBD patients. The dual focus on inflammation and fibrosis positions obefazimod as a potentially transformative therapy for a significant unmet need.

The Cannabist Company has secured an extended forbearance agreement with its senior noteholders. This crucial extension provides the cannabis firm with necessary time to navigate financial complexities, restructure debt, and implement strategic initiatives. It signals confidence from lenders in the company’s management and its plan for recovery and growth, allowing focus on operational improvements and market expansion within the dynamic cannabis sector.

VERSES Technologies filed its Q4 2025 Form 10-Q, detailing financial results and operational highlights. The report emphasizes advancements in edge AI, robotics, and data security, showcasing the company’s strategy for autonomous systems. Investors are closely watching growth, profitability, and market penetration amidst a rapidly evolving AI and robotics landscape.

Western Copper and Gold Corp. has filed a short form prospectus, a key step towards raising capital. This move will likely fund the advancement of their significant Casino Project in Yukon, a major copper-gold porphyry deposit with substantial resource potential. The company’s strategy anticipates leveraging market conditions and technological advancements to progress this large-scale development.

IBC Advanced Alloys Corp. secured US$1.25 million from The Lind Partners to boost operations and accelerate commercialization of its advanced materials, especially for aerospace and defense. This funding validates IBC’s proprietary Beryllium-enhanced alloys and additive manufacturing, known for superior strength-to-weight, high-temperature performance, and corrosion resistance. The capital will enhance manufacturing, support R&D for new applications, and capitalize on growing demand for high-performance materials.

Realtor.com® CEO David Conrad detailed the company’s SXSW 2026 focus on bridging the digital divide in real estate. Innovations in AI/ML, XR, data analytics, and blockchain aim to enhance accessibility, transparency, and user experience. These advancements will address market volatility, information asymmetry, and transaction friction, fostering a more connected and human-centric real estate ecosystem.

Abbott Laboratories declared its 409th consecutive quarterly dividend, showcasing over a century of consistent financial strength and dedication to shareholders. This enduring payout reflects a robust healthcare portfolio across medical devices, diagnostics, nutrition, and pharmaceuticals, supported by innovation and market leadership. Abbott’s dividend policy signals confidence in its business model and sustained profitability, making it a reliable investment and a key indicator in the healthcare sector.

VGTel, Inc. (VGTL) issued a statement clarifying its science-based approach to sensor technology and data analysis in light of public interest in UAP. The company emphasizes its focus on empirical observation and rigorous scientific principles for environmental monitoring, rather than speculative interpretations. VGTel’s multi-modal sensing and proprietary algorithms aim to provide objective data for understanding complex patterns and detecting anomalies, contributing to scientific advancement across various sectors.